Digital Look

Welcome to Digital Look++,
you are not logged in

RTW Biotech Opportunities Ltd (RTW)

Investment Firms

$ 1.49

Select chart: EPS | Dividend | Revenue

Period Ending	Period	Revenue ($m)	Pre-tax ($m)	EPS	Dividend
30-Jun-25	Interim	29.79	19.34	5.86¢	n/a

Year Ending	Revenue ($m)	Pre-tax ($m)	EPS	P/E	PEG	EPS Grth.	Div	Yield
31-Dec-20	0.15	(4.95)	(2.59)¢	n/a	n/a	n/a	n/a	0.0%
31-Dec-21	0.66	(7.80)	(3.67)¢	n/a	n/a	n/a	n/a	0.0%
31-Dec-22	2.17	(5.29)	(2.24)¢	n/a	n/a	n/a	n/a	0.0%
31-Dec-23	4.17	(4.76)	(2.26)¢	n/a	n/a	n/a	n/a	0.0%
31-Dec-24	8.19	(8.74)	(2.60)¢	n/a	n/a	n/a	n/a	0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts data is not available for this company.

	5 Yr High	5 Yr Low	5 Yr Avg	Curr / Avg
Latest	n/a	n/a	n/a	0

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

Find out about IFRS and how this affects the financial infomation for all UK companies.